2025-524043-12-00RecruitingPhase 1
A study to learn more about the safety and effects of a new blood-thinning medicine, given alone and together with another blood-thinner, in healthy adults
Source: EU CTIS (euclinicaltrials.eu) · Last updated 1 Oct 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- First submitted
- 18 Feb 2026
- Start date
- 13 May 2026
- Lead sponsor
- Bayer AG
- EU CT number
- 2025-524043-12-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 72
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CRS Clinical Research Services Berlin GmbH | Berlin | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.